Geranylgeranylacetone protects the heart via caveolae and caveolin-3

Life Sciences

Volumn 101, Issue 1-2, 2014, Pages 43-48

  Tsutsumi, Yasuo M ^a   Tsutsumi, Rie ^a   Horikawa, Yousuke T ^a   Sakai, Yoko ^a   Hamaguchi, Eisuke ^a   Ishikawa, Yoshihiro ^b   Yokoyama, Utako ^b   Kasai, Asuka ^a   Kambe, Noriko ^a   Tanaka, Katsuya ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Cardiac protection; Caveolae; Caveolin; Geranylgeranylacetone; Heat shock protein

Indexed keywords

CAVEOLIN 3; HEAT SHOCK PROTEIN 70; TEPRENONE; TROPONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CAVEOLA; CHEMICAL ANALYSIS; CONTROLLED STUDY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; MALE; MITOCHONDRION SWELLING; MOUSE; NONHUMAN; REPERFUSION INJURY;

MUS;

CARDIAC PROTECTION; CAVEOLAE; CAVEOLIN; GERANYLGERANYLACETONE; HEAT SHOCK PROTEIN;

ANIMALS; CARDIOTONIC AGENTS; CAVEOLAE; CAVEOLIN 3; DITERPENES; MALE; MICE; MICE, KNOCKOUT; MITOCHONDRIAL SWELLING; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; TROPONIN;

EID: 84897583172     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.02.019     Document Type: Article

References (35)

1. R.G. Anderson Potocytosis of small molecules and ions by caveolae Trends Cell Biol 3 1993 69 72
2. A.T. Black, P.J. Hayden, R.P. Casillas, D.E. Heck, D.R. Gerecke, and P.J. Sinko et al. Regulation of Hsp27 and Hsp70 expression in human and mouse skin construct models by caveolae following exposure to the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide Toxicol Appl Pharmacol 253 2011 112 120
3. B.J. Brundel, R.H. Henning, L. Ke, I.C. van Gelder, H.J. Crijns, and H.H. Kampinga Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation J Mol Cell Cardiol 41 2006 555 562
4. B.J. Brundel, A. Shiroshita-Takeshita, X. Qi, Y.H. Yeh, D. Chartier, and I.C. van Gelder et al. Induction of heat shock response protects the heart against atrial fibrillation Circ Res 99 2006 1394 1402
5. D.R. Ciocca, F.D. Cuello-Carrion, A.L. Natoli, C. Restall, and R.L. Anderson Absence of caveolin-1 alters heat shock protein expression in spontaneous mammary tumors driven by Her-2/neu expression Histochem Cell Biol 137 2012 187 194
6. H.N. Fridolfsson, Y. Kawaraguchi, S.S. Ali, M. Panneerselvam, I.R. Niesman, and J.C. Finley et al. Mitochondria-localized caveolin in adaptation to cellular stress and injury FASEB J 26 2012 4637 4649
7. T. Fujimoto Calcium pump of the plasma membrane is localized in caveolae J Cell Biol 120 1993 1147 1157
8. M. Fujimoto, T. Yamanaka, M. Bessho, and T. Igarashi Effects of geranylgeranylacetone on gastrointestinal secretion in rats Eur J Pharmacol 77 1982 113 118
9. Y. Hagiwara, T. Sasaoka, K. Araishi, M. Imamura, H. Yorifuji, and I. Nonaka et al. Caveolin-3 deficiency causes muscle degeneration in mice Hum Mol Genet 9 2000 3047 3054
10. T. Hirakawa, K. Rokutan, T. Nikawa, and K. Kishi Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa Gastroenterology 111 1996 345 357
11. K. Hirose, Y.M. Tsutsumi, R. Tsutsumi, M. Shono, E. Katayama, and M. Kinoshita et al. Role of the O-linked beta-N-acetylglucosamine in the cardioprotection induced by isoflurane Anesthesiology 115 2011 955 962
12. Y.T. Horikawa, H.H. Patel, Y.M. Tsutsumi, M.M. Jennings, M.W. Kidd, and Y. Hagiwara et al. Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury J Mol Cell Cardiol 44 2008 123 130
13. Y.T. Horikawa, M. Panneerselvam, Y. Kawaraguchi, Y.M. Tsutsumi, S.S. Ali, and R.C. Balijepalli et al. Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling J Am Coll Cardiol 57 2011 2273 2283
14. H. Kitahata, J. Nozaki, S. Kawahito, T. Tomino, and S. Oshita Low-dose sevoflurane inhalation enhances late cardioprotection from the anti-ulcer drug geranylgeranylacetone Anesth Analg 107 2008 755 761
15. M.P. Lisanti, P.E. Scherer, Z. Tang, and M. Sargiacomo Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis Trends Cell Biol 4 1994 231 235
16. M. Murakami, K. Oketani, H. Fujisaki, T. Wakabayashi, and T. Ohgo Antiulcer effect of geranylgeranylacetone, a new acyclic polyisoprenoid on experimentally induced gastric and duodenal ulcers in rats Arzneimittelforschung 31 1981 799 804
17. T. Ooie, N. Takahashi, T. Saikawa, T. Nawata, M. Arikawa, and K. Yamanaka et al. Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart Circulation 104 2001 1837 1843
18. T. Ooie, M. Kajimoto, N. Takahashi, T. Shinohara, Y. Taniguchi, and H. Kouno et al. Effects of insulin resistance on geranylgeranylacetone-induced expression of heat shock protein 72 and cardioprotection in high-fat diet rats Life Sci 77 2005 869 881
19. R.S. Ostrom, C. Gregorian, R.M. Drenan, Y. Xiang, J.W. Regan, and P.A. Insel Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase J Biol Chem 276 2001 42063 42069
20. R.S. Ostrom, X. Liu, B.P. Head, C. Gregorian, T.M. Seasholtz, and P.A. Insel Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains Mol Pharmacol 62 2002 983 992
21. G. Palade Fine structure of blood capillaries J Appl Phys 24 1953 1424 1436
22. H.H. Patel, Y.M. Tsutsumi, B.P. Head, I.R. Niesman, M. Jennings, and Y. Horikawa et al. Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin-1 FASEB J 21 2007 1565 1574
23. H.H. Patel, F. Murray, and P.A. Insel Caveolae as organizers of pharmacologically relevant signal transduction molecules Annu Rev Pharmacol Toxicol 48 2008 359 391
24. M. Sakabe, A. Shiroshita-Takeshita, A. Maguy, B.J. Brundel, A. Fujiki, and H. Inoue et al. Effects of a heat shock protein inducer on the atrial fibrillation substrate caused by acute atrial ischaemia Cardiovasc Res 78 2008 63 70
25. T. Shinohara, N. Takahashi, H. Kohno, K. Yamanaka, T. Ooie, and O. Wakisaka et al. Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart Am J Physiol Heart Circ Physiol 293 2007 H1892 H1899
26. S.F. Steinberg, and L.L. Brunton Compartmentation of G protein-coupled signaling pathways in cardiac myocytes Annu Rev Pharmacol Toxicol 41 2001 751 773
27. Y.M. Tsutsumi, H.H. Patel, N.C. Lai, T. Takahashi, B.P. Head, and D.M. Roth Isoflurane produces sustained cardiac protection after ischemia-reperfusion injury in mice Anesthesiology 104 2006 495 502
28. Y.M. Tsutsumi, T. Yokoyama, Y. Horikawa, D.M. Roth, and H.H. Patel Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization Life Sci 81 2007 1223 1227
29. Y.M. Tsutsumi, Y.T. Horikawa, M.M. Jennings, M.W. Kidd, I.R. Niesman, and U. Yokoyama et al. Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning Circulation 118 2008 1979 1988
30. Y.M. Tsutsumi, Y. Kawaraguchi, Y.T. Horikawa, I.R. Niesman, M.W. Kidd, and B. Chin-Lee et al. Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection Anesthesiology 112 2010 1136 1145
31. Y.M. Tsutsumi, Y. Kawaraguchi, I.R. Niesman, H.H. Patel, and D.M. Roth Opioid-induced preconditioning is dependent on caveolin-3 expression Anesth Analg 111 2010 1117 1121
32. Y.M. Tsutsumi, R. Tsutsumi, K. Mawatari, Y. Nakaya, M. Kinoshita, and K. Tanaka et al. Compound K, a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/PI3K pathway Life Sci 88 2011 725 729
33. K. Yamamoto, M. Sarukawa, T. Ito, H. Aoki, M. Ichida, and K. Shimada An anti-ulcer drug, geranylgeranylacetone, suppresses inducible nitric oxide synthase in cultured vascular smooth muscle cells J Hypertens 23 2005 1847 1853
34. K. Yamanaka, N. Takahashi, T. Ooie, K. Kaneda, H. Yoshimatsu, and T. Saikawa Role of protein kinase C in geranylgeranylacetone-induced expression of heat-shock protein 72 and cardioprotection in the rat heart J Mol Cell Cardiol 35 2003 785 794
35. Z. Zhu, N. Takahashi, T. Ooie, T. Shinohara, K. Yamanaka, and T. Saikawa Oral administration of geranylgeranylacetone blunts the endothelial dysfunction induced by ischemia and reperfusion in the rat heart J Cardiovasc Pharmacol 45 2005 555 562